Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacy. [PDF]
Veldkamp SR +18 more
europepmc +1 more source
Subclinical Atherosclerosis Risk Can Be Predicted in Female Patients With Systemic Lupus Erythematosus Using Metabolomic Signatures: An Observational Study. [PDF]
Woodridge L +12 more
europepmc +1 more source
Type I interferon signature: a quantitative standardized method for clinical application. [PDF]
Tesser A +12 more
europepmc +1 more source
Therapeutic potential of TAM receptors in autoimmune diseases: insights from original studies. [PDF]
Adedayo SI +8 more
europepmc +1 more source
Limited Sensitivity and Specificity of the ACR/EULAR-2019 Classification Criteria for SLE in JSLE?—Observations From the UK JSLE Cohort Study [PDF]
Abstract Objectives This study aimed to test the performance of the new ACR and EULAR criteria, that include ANA positivity as entry criterion, in JSLE. Methods Performance of the ACR/EULAR-2019 criteria were compared with Systemic ...
Robert J Moots +2 more
exaly +6 more sources
Global Prevalence of JIA, JSLE and Club Foot [PDF]
Jessica McHugh
exaly +3 more sources
1675 Real World Treatment of Juvenile Systemic Lupus Erythematosus (JSLE): Evidence From the UK JSLE Cohort Study [PDF]
Christian M Hedrich +2 more
exaly +2 more sources

